Home
About Us
Company profile Culture CEO speechHistory Honors Company
/about.html
Products
Finished ProductsAPIsIntermediates
/about.html
R&D
R&D profile R&D teamR&D cooperate R&D achievement CDMO
/about.html

Zhejiang Yongning Pharmaceutical Co., Ltd.,
Media center
Join Us
Recruit Train Talent concept
/about.html
Contact Us
Contact Order Position
/about.html
Chinese
About Us

About Us

Company profile Culture CEO speechHistory Honors Company
yongning
Company profile
永无止境，宁静致远
公司简介Zhejiang Yongning Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is a pharmaceutical enterprise mainly engaged in the research and development and production of innovative drugs and preparations. It is a national high-tech enterprise, an innovative pilot enterprise and a patent demonstration enterprise in Zhejiang Province.

Founded in 1974, the company is the first industrial enterprise in Taizhou with an annual sales of more than 100 million yuan. It was restructured into a joint-stock enterprise in 2007, with a registered capital of 153.125 million yuan and a warehousing tax of more than 100 million yuan. It is a "large taxpayer in Zhejiang Province", covering 140000 square meters, and has more than 1300 employees, including 50 masters, 6 doctors, more than 300 professional and technical personnel, 23 people with senior professional titles. It has more than 100 products in five categories, including chemical preparations, chemical pharmaceutical intermediates, APIs, traditional Chinese patent medicines and simple preparations, and health care products.

The company's flagship product, injection grade safflower yellow pigment, has been included in the national "863" plan and has won the National Key New Product Certificate, Zhejiang Province Patent Award Gold Award, Zhejiang Province Science and Technology Progress Second Prize. It is also the first Chinese medicine second-class protected variety. The Xinjiang safflower planting base has been rated as a "high-quality authentic medicinal material (safflower) demonstration base".

The company has fully passed the national new version of GMP certification, and some products have been certified by the US FDA, Japan PMDA, and South Korea KFDA. Among them, Cefoperam Hydrochloride is a standard product of the US Pharmacopeia. The company is currently focusing on tackling multiple new drug projects, one of which has been listed as a major national special project. It has applied for more than 80 domestic and foreign patents and has been granted 50 patents, including 9 foreign patents (4 US patents). The company has established a provincial-level postdoctoral workstation and research and development institutions in multiple universities in Beijing, Shanghai, Nanjing, and other places. It has been listed as a provincial-level high-tech enterprise research and development center.
Culture
Culture
Development strategy is the lifeblood of a company;
Innovation is the soul of enterprise development;
A community of shared destiny for enterprises and employees;
Talents are the most important resource for enterprises;
Win win cooperation among all parties in the market;
Fulfilling social responsibility is the foundation of a company's survival and development.
yongning
CEO speech
永无止境，宁静致远
Born here, grew up here! Based locally, facing the world!

After forty years of trials and tribulations, Yongning Pharmaceutical has always been at the forefront of China's reform and opening up and pharmaceutical development, adhering to the principle of human health, upholding the principle of legality and trustworthiness, practicing the concept of innovative development, and implementing the strategy of talent entrepreneurship. Today, it has grown into a pharmaceutical enterprise mainly engaged in research and development and production of innovative drugs and preparations. It is a national high-tech enterprise, an innovative pilot enterprise in Zhejiang Province, and a patent demonstration enterprise.

Yongning Pharmaceutical insists on developing innovative drugs as its core competitiveness, and efficient, ethical, and in-depth research behavior runs through the entire process of drug and treatment development. Every crucial decision we make is executed under supervision.

Yongning Pharmaceutical always adheres to the corporate spirit of "endless, peaceful and far-reaching", pursuing endless innovation, endless struggle, and endless development!

The sea embraces all rivers, and tolerance is great. Yongning Pharmaceutical follows the laws of pharmaceutical development, warmly welcomes friends from the pharmaceutical industry around the world, and jointly builds a modern pharmaceutical enterprise that is standardized, professional, digital, international, and public!
董事长致辞
yongning
History
永无止境，宁静致远
1974

The company was founded in 1974 and is the first industrial enterprise in Taizhou region with annual sales exceeding 100 million yuan

1987

In 1987, Yongning Pharmaceutical successfully developed cephalosporin side chains

1989

The Dinka project of Yongning Pharmaceutical was officially put into operation in 1989

1991

Entrusted to manage enterprises from both countries in 1991

1993

Annual sales revenue first exceeded 100 million (Taizhou)

First GMP certification (powder injection production line)

2001

Passed ISO9002 quality system certification in 2001

2007

On June 28, 2007, the company was successfully restructured and officially renamed Zhejiang Yongning Pharmaceutical Co., Ltd

2010

In 2010, sterile raw materials passed the PMDA certification in Japan

2011

In 2011, the first domestically produced sterile raw material drug production line passed the FDA audit in the United States

2014

In 2014, the storage tax exceeded 100 million yuan for the first time, achieving an annual production of 30 million bottles of injectable safflower yellow pigment

2016

Donate a total of 3 million yuan to Xiamen University, China Pharmaceutical University, and Fudan University, and establish the "Zhao Yufen Zhejiang Yongning Pharmaceutical Award" at Xiamen University

2017

Established a provincial-level postdoctoral workstation in 2017

yongning
Honors
永无止境，宁静致远
In 1997, Chairman Ye Fengqi was awarded the honorary title of
In 1997, Chairman Ye Fengqi was awarded the honorary title of "National Excellent Township Enterprise Factory Director (Manager, Chairman)"
The company's labor union has been awarded the honorary title of
The company's labor union has been awarded the honorary title of "Model Workers' Home"
National Export Earning - Advanced Township Enterprises
National Export Earning - Advanced Township Enterprises
Honors
Honors
Zhejiang Province Innovative Pilot Enterprise
Zhejiang Province Innovative Pilot Enterprise
The company's development department has been awarded the honorary title of
The company's development department has been awarded the honorary title of "National Female Employee Model Post for Achievements and Achievements"
In 2010, Deputy General Manager Lu Min won the honorary title of
In 2010, Deputy General Manager Lu Min won the honorary title of "National model worker"
High tech Enterprise Certificate
High tech Enterprise Certificate
Excellent Private Enterprise in Zhejiang Province
Excellent Private Enterprise in Zhejiang Province
The company was ranked among the top ten non listed industrial enterprises with the highest investment value in the national pharmaceutical industry in 2011 and 2012
The company was ranked among the top ten non listed industrial enterprises with the highest investment value in the national pharmaceutical industry in 2011 and 2012
In 2012, Chairman Ye Fengqi (fourth from the right in the back row) was awarded the honorary title of
In 2012, Chairman Ye Fengqi (fourth from the right in the back row) was awarded the honorary title of
General Manager Ye Tianjian was awarded the honorary title of
General Manager Ye Tianjian was awarded the honorary title of
yongning
Company
永无止境，宁静致远